These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 30615816)

  • 1. Incidence and risk factors for hepatocellular cancer in individuals with haemophilia: A National Inpatient Sample Study.
    Thalappillil A; Ragni MV; Comer DM; Yabes JG
    Haemophilia; 2019 Mar; 25(2):221-228. PubMed ID: 30615816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and risk factors for hepatocellular carcinoma in individuals with haemophilia in the era of direct-acting antiviral agents: A national inpatient sample study.
    Yang X; Jeong K; Yabes JG; Ragni MV
    Haemophilia; 2022 Sep; 28(5):769-775. PubMed ID: 35727998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of diabetes in hepatocellular carcinoma: a case-control study among United States Veterans.
    El-Serag HB; Richardson PA; Everhart JE
    Am J Gastroenterol; 2001 Aug; 96(8):2462-7. PubMed ID: 11513191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in incidence of hepatocellular carcinoma after diagnosis of hepatitis B or C infection: a population-based cohort study, 1992-2007.
    Thein HH; Walter SR; Gidding HF; Amin J; Law MG; George J; Dore GJ
    J Viral Hepat; 2011 Jul; 18(7):e232-41. PubMed ID: 21692938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus-related complications are increasing in women veterans: A national cohort study.
    Kramer JR; El-Serag HB; Taylor TJ; White DL; Asch SM; Frayne SM; Cao Y; Smith DL; Kanwal F
    J Viral Hepat; 2017 Nov; 24(11):955-965. PubMed ID: 28815822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in Incidences and Risk Factors for Hepatocellular Carcinoma and Other Liver Events in HIV and Hepatitis C Virus-coinfected Individuals From 2001 to 2014: A Multicohort Study.
    Gjærde LI; Shepherd L; Jablonowska E; Lazzarin A; Rougemont M; Darling K; Battegay M; Braun D; Martel-Laferriere V; Lundgren JD; Rockstroh JK; Gill J; Rauch A; Mocroft A; Klein MB; Peters L
    Clin Infect Dis; 2016 Sep; 63(6):821-829. PubMed ID: 27307505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of Metabolic Risk Factors on Risk of Hepatocellular Carcinoma and Liver-Related Death in Men With Chronic Hepatitis B: A Large Cohort Study.
    Yu MW; Lin CL; Liu CJ; Yang SH; Tseng YL; Wu CF
    Gastroenterology; 2017 Oct; 153(4):1006-1017.e5. PubMed ID: 28711626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of hepatocellular carcinoma among older Americans attributable to hepatitis C and hepatitis B: 2001 through 2013.
    Shiels MS; Engels EA; Yanik EL; McGlynn KA; Pfeiffer RM; O'Brien TR
    Cancer; 2019 Aug; 125(15):2621-2630. PubMed ID: 30980394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Assessment of Hepatocellular Carcinoma in Patients with Hepatitis C in China and the USA.
    Parikh ND; Fu S; Rao H; Yang M; Li Y; Powell C; Wu E; Lin A; Xing B; Wei L; Lok ASF
    Dig Dis Sci; 2017 Nov; 62(11):3243-3253. PubMed ID: 28948495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlates, Trends, and Short-Term Outcomes of Venous Thromboembolism in Hospitalized Patients with Hepatocellular Carcinoma.
    Al-Taee AM; Mohammed KA; Khneizer GW; Neuschwander-Tetri BA
    J Gastrointest Cancer; 2019 Jun; 50(2):357-360. PubMed ID: 31006830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents.
    Kanwal F; Kramer J; Asch SM; Chayanupatkul M; Cao Y; El-Serag HB
    Gastroenterology; 2017 Oct; 153(4):996-1005.e1. PubMed ID: 28642197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bleeding and liver transplantation outcomes in haemophilia.
    Mehta KD; Ragni MV
    Haemophilia; 2017 Mar; 23(2):230-237. PubMed ID: 27813318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high-risk for hepatocellular carcinoma.
    Lu SN; Wang JH; Liu SL; Hung CH; Chen CH; Tung HD; Chen TM; Huang WS; Lee CM; Chen CC; Changchien CS
    Cancer; 2006 Nov; 107(9):2212-22. PubMed ID: 17019738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis C.
    García-Samaniego J; Rodríguez M; Berenguer J; Rodríguez-Rosado R; Carbó J; Asensi V; Soriano V
    Am J Gastroenterol; 2001 Jan; 96(1):179-83. PubMed ID: 11197250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral hepatitis and hepatocellular carcinoma.
    Sallie R; Di Bisceglie AM
    Gastroenterol Clin North Am; 1994 Sep; 23(3):567-79. PubMed ID: 7989095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of hepatocellular carcinoma (HCC) in hemophilia.
    Shetty S; Sharma N; Ghosh K
    Crit Rev Oncol Hematol; 2016 Mar; 99():129-33. PubMed ID: 26754251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocellular carcinoma and hepatitis C in the United States.
    El-Serag HB
    Hepatology; 2002 Nov; 36(5 Suppl 1):S74-83. PubMed ID: 12407579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001-2013.
    Beste LA; Leipertz SL; Green PK; Dominitz JA; Ross D; Ioannou GN
    Gastroenterology; 2015 Nov; 149(6):1471-1482.e5; quiz e17-8. PubMed ID: 26255044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C. UK Haemophilia Centre Directors' Organisation.
    Darby SC; Ewart DW; Giangrande PL; Spooner RJ; Rizza CR; Dusheiko GM; Lee CA; Ludlam CA; Preston FE
    Lancet; 1997 Nov; 350(9089):1425-31. PubMed ID: 9371165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin resistance is associated with a higher risk of hepatocellular carcinoma in cirrhotic HIV/HCV-co-infected patients: results from ANRS CO13 HEPAVIH.
    Salmon D; Bani-Sadr F; Loko MA; Stitou H; Gervais A; Durant J; Rosenthal E; Quertainmont Y; Barange K; Vittecoq D; Shoai-Tehrani M; Alvarez M; Winnock M; Trinchet JC; Dabis F; Sogni P
    J Hepatol; 2012 Apr; 56(4):862-8. PubMed ID: 22173166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.